Which stocks in any sector do Indian mutual fund managers prefer most? — May 2026 data
| # | Stock Name | No. of MFs Holding | Avg Weight (%) | Total MF Value (Cr) |
|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 418 funds | 2.54% | ₹53,045 Cr |
| 2 | Divi's Laboratories Limited | 286 funds | 2.13% | ₹22,610 Cr |
| 3 | Cipla Limited | 262 funds | 1.61% | ₹22,029 Cr |
| 4 | Dr. Reddy's Laboratories Limited | 242 funds | 1.68% | ₹15,838 Cr |
| 5 | Torrent Pharmaceuticals Limited | 225 funds | 1.57% | ₹6,552 Cr |
| 6 | Lupin Limited | 220 funds | 1.59% | ₹16,018 Cr |
| 7 | Glenmark Pharmaceuticals Limited | 189 funds | 1.37% | ₹8,321 Cr |
| 8 | Mankind Pharma Limited | 189 funds | 1.13% | ₹10,388 Cr |
| 9 | Aurobindo Pharma Limited | 179 funds | 1.49% | ₹8,761 Cr |
| 10 | Ajanta Pharma Limited | 160 funds | 0.91% | ₹5,402 Cr |
| 11 | Alkem Laboratories Limited | 159 funds | 1.24% | ₹10,326 Cr |
| 12 | Laurus Labs Limited | 156 funds | 2.00% | ₹5,955 Cr |
| 13 | Abbott India Limited | 154 funds | 0.95% | ₹4,222 Cr |
| 14 | JB Chemicals & Pharmaceuticals Limited | 148 funds | 1.39% | ₹6,336 Cr |
| 15 | Biocon Limited | 142 funds | 1.14% | ₹10,268 Cr |
| 16 | IPCA Laboratories Limited | 140 funds | 1.06% | ₹11,885 Cr |
| 17 | Sai Life Sciences Limited | 136 funds | 1.24% | ₹6,953 Cr |
| 18 | Zydus Lifesciences Limited | 134 funds | 0.95% | ₹4,644 Cr |
| 19 | Anthem Biosciences Limited | 126 funds | 0.64% | ₹3,440 Cr |
| 20 | Gland Pharma Limited | 124 funds | 1.16% | ₹10,668 Cr |
The table above ranks the top 20 stocks in the Pharmaceuticals & Biotechnology sector by the number of Indian mutual fund schemes holding them as of May 2026. When a large number of fund managers independently choose the same stock, it is a powerful signal of institutional conviction — these are the stocks that professional money managers believe in most.
A stock held by 200+ mutual funds means that hundreds of fund managers — each doing their own independent research — have concluded that this stock deserves a place in their portfolio. This collective wisdom is one of the most reliable indicators of a stock's quality within its sector. The average weight shows how much of their portfolio each fund typically allocates to the stock, and the total MF value shows the combined rupee investment across all funds holding it.
All data is sourced from monthly portfolio disclosures that every AMFI-registered mutual fund is required to publish. RightAdvise compiles and analyses this data across 1,100+ active fund schemes to give you a clear, unbiased view of where professional fund managers are investing in the Pharmaceuticals & Biotechnology sector. Click any stock name in the table to see which specific funds hold it and in what proportion.